Page last updated: 2024-12-07
dichloroacetic anhydride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
dichloroacetic anhydride: metabolite of trichloroethene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 77772 |
| SCHEMBL ID | 187025 |
| MeSH ID | M0521783 |
Synonyms (29)
| Synonym |
|---|
| anhydrid kyseliny dichloroctove |
| mb3ogr64in , |
| acetic acid, 2,2-dichloro-, 1,1'-anhydride |
| unii-mb3ogr64in |
| dichloroacetetic anhydride |
| brn 0512173 |
| nsc 401832 |
| einecs 223-924-8 |
| 2,2'-dichloroacetic anhydride |
| acetic acid, dichloro-, anhydride |
| anhydrid kyseliny dichloroctove [czech] |
| nsc401832 |
| wln: gygvovygg |
| nsc-401832 |
| dichloroacetic acid anhydride |
| dichloroacetic anhydride |
| 4124-30-5 |
| dichloroacetic anhydride, technical grade, 85% |
| inchi=1/c4h2cl4o3/c5-1(6)3(9)11-4(10)2(7)8/h1-2h |
| rqhmqurgsqbbjy-uhfffaoysa- |
| (2,2-dichloroacetyl) 2,2-dichloroacetate |
| FT-0624699 |
| AKOS015913191 |
| SCHEMBL187025 |
| mfcd00000842 |
| DTXSID5041011 |
| dichloroacetic anhydride, technical, >=94% (t) |
| Q27283787 |
| 2,2-dichloroacetic anhydride |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 17.53
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.53) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||